Back to News
Market Impact: 0.75

Stocks Rally as Weak US Jobs News Reinforces Fed Rate Cut Hopes

SPYDIAQQQPFEAZNLLYMRKREGNMRNABIIBAMGNBMYSMCIMUINTCAMATLRCXARMKLACASMLCOINGLXYMARAMSTRLACAESBLKNKECVNAIOTCTVAMELIAMZNDOCSGSDLTRDGBJKRWMTGEVRYANGOGMGINDAQ
Market Technicals & FlowsEconomic DataMonetary PolicyInterest Rates & YieldsFiscal Policy & BudgetCorporate EarningsHealthcare & BiotechTechnology & Innovation
Stocks Rally as Weak US Jobs News Reinforces Fed Rate Cut Hopes

U.S. stock indexes, including the S&P 500 and Nasdaq 100, posted new all-time highs Wednesday, recovering from early losses. The rally was primarily driven by an unexpected contraction in September ADP employment, which cemented market expectations for a 100% probability of a Fed rate cut at the October FOMC meeting, alongside a stronger-than-expected ISM manufacturing index. Despite an ongoing government shutdown causing initial market jitters and delaying key economic reports, strong Q3 corporate earnings expectations and significant gains in pharmaceutical and chipmaker stocks provided further support.

Analysis

U.S. equity markets rallied to new all-time highs for the S&P 500 and Nasdaq 100, closing up +0.34% and +0.49% respectively, driven by a complex interplay of macroeconomic signals and sector-specific news. The primary catalyst was the September ADP employment report, which unexpectedly contracted by 32,000, marking the largest decline in 2.5 years and cementing market expectations for a 100% probability of a 25 bp Fed rate cut at the October FOMC meeting. This dovish outlook pushed the 10-year T-note yield down 5 bp. Despite this sign of economic weakness, the September ISM manufacturing index rose to a 7-month high of 49.1, although its prices paid sub-index fell to an 8-month low, suggesting easing inflation. The market's advance occurred against the backdrop of a U.S. government shutdown, which is delaying key economic data releases and initially spurred risk-off sentiment. Sector-level performance was robust, with pharmaceutical stocks like AstraZeneca (+9%) and Eli Lilly (+8%) surging on hopes of tariff reprieves, while chipmakers such as Super Micro Computer (+9%) and Micron Technology (+8%) also saw significant gains. This bullish sentiment is further underpinned by strong Q3 corporate earnings expectations, with S&P 500 earnings growth projected at +6.9% and a record number of companies issuing positive guidance. However, company-specific news created significant divergence, with Corteva (CTVA) falling over 9% on its split announcement and MercadoLibre (MELI) dropping over 8% due to increased competitive pressure from Amazon in Brazil.